Northwestern Mutual Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26
Closed -$24 3906
2024
Q1
$24 Hold
26
﹤0.01% 3505
2023
Q4
$53 Hold
26
﹤0.01% 3406
2023
Q3
$95 Hold
26
﹤0.01% 3205
2023
Q2
$121 Hold
26
﹤0.01% 3260
2023
Q1
$121 Sell
26
-60
-70% -$337 ﹤0.01% 3235
2022
Q4
$387 Buy
86
+50
+139% +$322 ﹤0.01% 3145
2022
Q3
$0 Buy
36
+10
+38% +$350 ﹤0.01% 3519
2022
Q2
$1K Hold
26
﹤0.01% 3128
2022
Q1
$4K Hold
26
﹤0.01% 2829
2021
Q4
$4K Hold
26
﹤0.01% 2866
2021
Q3
$13K Hold
26
﹤0.01% 2380
2021
Q2
$13K Sell
26
-7
-21% -$3.76K ﹤0.01% 2355
2021
Q1
$17K Buy
33
+7
+27% +$3.61K ﹤0.01% 2128
2020
Q4
$12K Hold
26
﹤0.01% 2144
2020
Q3
$7K Hold
26
﹤0.01% 2109
2020
Q2
$5K Hold
26
﹤0.01% 2087
2020
Q1
$3K Hold
26
﹤0.01% 2206
2019
Q4
$5K Hold
26
﹤0.01% 2094
2019
Q3
$4K Hold
26
﹤0.01% 2167
2019
Q2
$3K Hold
26
﹤0.01% 2273
2019
Q1
$4K Hold
26
﹤0.01% 2209
2018
Q4
$3K Buy
+26
New +$3.99K ﹤0.01% 2163

Other funds holding AMPE

Northwestern Mutual Wealth Management's AMPE Position: Q2 2024 in Review

Northwestern Mutual Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 26 shares — an estimated $24 sold.

Northwestern Mutual Wealth Management first reported a position in AMPE in Q4 2018 and held it in 22 quarters. The position peaked at $17K in Q1 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • Northwestern Mutual Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 26 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $24.
  • Northwestern Mutual Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 22 quarters.
  • Northwestern Mutual Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $17K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.